Dr. Makker on Synergy Between Lenvatinib and Pembrolizumab in Endometrial Cancer

Vicky Makker, MD, medical oncologist, Memorial Sloan Kettering Cancer Center, discusses the synergy between lenvatinib and pembrolizumab in the treatment of patients with endometrial cancer.

• শ্রেণী